a month ago
PFE
AnalystsRobyn KarnauskasRobyn Karnauskas's Stock Forecasts
AnalystsRobyn Karnauskas
Analyst Ranking
Bottom 3%
#4287 out of 4414 analysts
Average Return
-9.02%
Win Rate
36%39 out of 109
Risk vs Reward
Poor
Good
Robyn Karnauskas's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunovant IncIMVT | +192.80% | $16.94 | $49.60 | 2020-01-09 - 2021-01-08 | Strong Buy |
Kodiak Sciences IncKOD | +116.19% | $69.35 | $149.93 | 2020-02-05 - 2021-02-05 | Strong Buy |
Arcus Biosciences IncRCUS | +106.37% | $13.97 | $28.83 | 2020-03-31 - 2021-04-01 | Strong Buy |
Immunovant IncIMVT | +74.47% | $20.64 | $36.01 | 2023-08-15 - 2023-11-28 | Strong Buy |
Bioxcel Therapeutics IncBTAI | +64.19% | $36.97 | $60.70 | 2020-02-13 - 2021-02-12 | Strong Buy |
Robyn Karnauskas Analyst Color
Get additional color on Robyn Karnauskas's coverage of popular stocks
4 months ago
LLY
10 months ago
MRK
Robyn Karnauskas's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 10 | Strong Buy | $1,045.00 | +30.44% | Reiterates | a day ago |
Coherus Biosciences IncCHRS | 9 | Strong Buy | $12.00 | +468.72% | Reiterates | a day ago |
Curis IncCRIS | 1 | Strong Buy | $26.00 | +117.21% | Initiates Coverage On | 12 days ago |
Tourmaline Bio IncTRML | 1 | Strong Buy | $43.00 | +139.55% | Initiates Coverage On | 12 days ago |
Immunovant IncIMVT | 4 | Strong Buy | $48.00 | +33.30% | Maintains | 14 days ago |
Amgen IncAMGN | 5 | Strong Buy | $320.00 | +20.52% | Upgrades | a month ago |
Pfizer IncPFE | 3 | Strong Buy | $42.00 | +41.46% | Maintains | a month ago |
Rayzebio IncRYZB | 1 | Strong Buy | $29.00 | +29.64% | Initiates Coverage On | 2 months ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $84.00 | +71.71% | Reiterates | 2 months ago |
Merck & Co IncMRK | 5 | Strong Buy | $122.00 | +21.78% | Reiterates | 2 months ago |
Ptc Therapeutics IncPTCT | 1 | Hold | $25.00 | +14.21% | Downgrades | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 9 | Strong Buy | $456.00 | +31.40% | Reiterates | 2 months ago |
Roivant Sciences LtdROIV | 4 | Strong Buy | $23.00 | +153.03% | Reiterates | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $140.00 | +59.53% | Reiterates | 2 months ago |
Nucana PLCNCNA | 2 | Strong Buy | $6.00 | +1,176.60% | Reiterates | 3 months ago |
Gilead Sciences IncGILD | 8 | Strong Buy | $91.00 | +22.13% | Reiterates | 3 months ago |
Arcus Biosciences IncRCUS | 4 | Strong Buy | $50.00 | +253.36% | Reiterates | 3 months ago |
Fate Therapeutics IncFATE | 3 | Hold | $7.00 | +176.68% | Reiterates | 3 months ago |
Absci CorpABSI | 2 | Strong Buy | $10.00 | +557.89% | Reiterates | 3 months ago |
Bioxcel Therapeutics IncBTAI | 4 | Strong Buy | $31.00 | +692.84% | Maintains | 3 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $600.00 | +1.42% | Maintains | 4 months ago |
Biogen IncBIIB | 11 | Strong Buy | $340.00 | +49.51% | Maintains | 4 months ago |
Uniqure NvQURE | 1 | Strong Buy | $55.00 | +687.97% | Maintains | 7 months ago |
Abbvie IncABBV | 6 | Strong Buy | $180.00 | +30.36% | Reiterates | 10 months ago |
Omniab IncOABI | 1 | Strong Buy | $10.00 | +136.41% | Initiates Coverage On | a year ago |
Mei Pharma IncMEIP | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | a year ago |
Instil Bio IncTIL | 2 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Kodiak Sciences IncKOD | 3 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Infinity Pharmaceuticals IncINFI | 2 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 3 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Dicerna Pharmaceuticals IncDRNA | 3 | Hold | $32.00 | N/A | Downgrades | 2 years ago |
Athenex IncATNXQ | 1 | Hold | $120.00 | N/A | Downgrades | 3 years ago |
Opthea LtdOPT | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Applied Therapeutics IncAPLT | 1 | Strong Buy | $85.00 | N/A | Initiates Coverage On | 3 years ago |
Celgene CorpCELG | 3 | Hold | $77.00 | N/A | Maintains | 5 years ago |
Alexion Pharmaceuticals IncALXN | 4 | Strong Buy | $190.00 | N/A | Maintains | 5 years ago |
Five Prime Therapeutics IncFPRX | 1 | Strong Buy | $44.00 | N/A | Maintains | 5 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | $63.00 | N/A | Maintains | 6 years ago |
Juno Therapeutics IncJUNO | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Kite Pharma IncKITE | 1 | Hold | $87.00 | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.